Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Reshape Lifesciences Q1 Earnings

  Reshape Lifesciences (NASDAQ:RSLS) reported its Q1 earnings results on Monday, May 23, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
May 23, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Reshape Lifesciences (NASDAQ:RSLS) reported its Q1 earnings results on Monday, May 23, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Reshape Lifesciences missed estimated earnings by 123.53%, reporting an EPS of $-0.38 versus an estimate of $-0.17.

Revenue was down $781.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.05 which was followed by a 1.48% increase in the share price the next day.

 

To track all earnings releases for Reshape Lifesciences visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Warrior Met Coal: Q2 Earnings Insights

By Benzinga Insights
Today, 11:04 AM
Warrior Met Coal (NYSE:HCC) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Warrior Met Coal beat estimated earnings by 18.11%, reporting an EPS of $5.87 versus an estimate of $4.97.

HCC